Home  /  Resource Library  /  The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice

Study investigated the effect of dose modification and interruption of ibrutinib on survival in patients with CLL.